Checked, not settled
Checks out so far.
“In the study’s eight-center external CT test cohorts, EAGLE achieved 98.5% specificity, 90.0% cancer sensitivity and 52.5% precancerous-lesion sensitivity.”
2 of 4 review checks done · 1 counted · 1 by the author only
Supported · 0.9781 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.
Share:
Checked in Galedra: score 0.98, strongly supported · not yet reviewed by anyone else “In the study’s eight-center external CT test cohorts, EAGLE achieved 98.5% specificity, 90.0% cancer sensitivity and 52.5% precancerous-lesion sensitivity.” https://galedra.org/claims/c57c9459-b73a-8122-8d93-5664d226efa5/card
Or just the link: https://galedra.org/claims/c57c9459-b73a-8122-8d93-5664d226efa5/card
